A patient is following up with their Health Care Provider (H…
A patient is following up with their Health Care Provider (HCP) for chronic asthma. They are currently taking tiotropium (Spiriva) scheduled and albuterol (Proair, Ventolin) prn for shortness of breath (SOB). Based on the patient’s assessment findings, the Health Care Provider (HCP) decides to prescribe fluticasone (Flovent) along with their current regimen. What statement by the patient would be most concerning by the nurse and warrant further education?